| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311864A1 Recombinant protein-s composition |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311834A1 Crystal of thiazolidinedione compound, and process for production thereof |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311822A1 Gpr119 agonist |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2311799A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311798A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311797A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311796A1 4-dedimethylamino tetracycline compounds |
| 04/20/2011 | EP2311494A1 Histone modification inhibitor specific to target gene |
| 04/20/2011 | EP2311472A1 Cognitive disorder-ameliorating agent |
| 04/20/2011 | EP2311463A1 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 04/20/2011 | EP2311453A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 04/20/2011 | EP2311452A1 Topical composition comprising n-acetyl glucosamine |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2311442A1 Multiparticulate modified release composition |
| 04/20/2011 | EP2311441A1 Dosage formulations for acetylcholinesterase inhibitors |
| 04/20/2011 | EP2311440A1 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 04/20/2011 | EP2311432A1 Prevention and reduction of blood loss |
| 04/20/2011 | EP2310973A2 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 04/20/2011 | EP2310037A2 Conglutin-gamma as medicament and diet supplement |
| 04/20/2011 | EP2309876A1 Nutritional composition containing oligosaccharide mixture |
| 04/20/2011 | EP1859793B1 Novel combinational use of a sulfonamide compound in the treatment of cancer |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | EP1449534B1 Ganoderma atrum extract as matrix metalloprotease inhibitor |
| 04/20/2011 | EP1399161B1 Sustained-release analgesic compounds |
| 04/20/2011 | EP1292592B1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 04/20/2011 | EP1082415B1 Methods useful for modulation of angiogenesis using tyrosine kinase src |
| 04/20/2011 | CN1872107B Chinese and Western compound preparations of alpha receptor blocking pharmacon, preparation method, and application |
| 04/20/2011 | CN1840087B King solomonseal- and fleece-flower root-containing Chinese medicinal formulation for treating chronic fatigue syndrome and its preparation method |
| 04/20/2011 | CN1795265B Control of stem cell differentiation induction and differentiation potency |
| 04/20/2011 | CN102027013A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102026664A Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 04/20/2011 | CN102026647A Pharmaceutical composition for treating or preventing cancer which induces dendritic cell-like differentiation of monocytes to increase anticancer immune activity |
| 04/20/2011 | CN102026641A Pharmaceutical preparation comprising DPP-IV inhibitor and other diabetes therapeutic agent in concomitant or combined form |
| 04/20/2011 | CN102026633A 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 04/20/2011 | CN102026629A Transdermally absorbable preparation |
| 04/20/2011 | CN102021153A Human telomerase catalytic subunit |
| 04/20/2011 | CN102020649A Diketopiperazine compound as well as composition, preparation method and application thereof |
| 04/20/2011 | CN102020643A dihydropteridine ketone derivative, and preparation method and medicinal application thereof |
| 04/20/2011 | CN102020639A 6-amido quinazoline or 3-cyano quinoline derivative, preparation method thereof and application of derivative to medicament |
| 04/20/2011 | CN102020638A 2-indolinone derivative with protein kinase inhibition activity and histone deacetylase inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020609A Tolvapta crystal or amorphous substance and preparation method thereof |
| 04/20/2011 | CN102020607A 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 04/20/2011 | CN102020588A Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 04/20/2011 | CN102020563A Novel curcumin analogues and uses thereof |
| 04/20/2011 | CN102018917A Traditional Chinese medicine pill for treating various polypi |
| 04/20/2011 | CN102018872A Chinese medicinal preparation for treating heat stroke |
| 04/20/2011 | CN102018840A Formula for treating summer-heat and damp |
| 04/20/2011 | CN102018773A Chinese traditional medicine preparation for treating hepatitis b, hepatomegaly and splenomegaly. |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018698A Compounds and methods for treating estrogen receptor-related diseases |
| 04/20/2011 | CN102018067A Formula of homemade sunstroke preventing and treating beverage and preparation method |
| 04/20/2011 | CN101590036B Application of epoxydiene taken as inhibitor of proinflammatory mediators |
| 04/20/2011 | CN101376655B Penicillazine derivative, and preparation and use thereof |
| 04/20/2011 | CN101199856B Oxygen-carrying anti-shock medicament |
| 04/20/2011 | CN101164535B Anti-heatstroke use of teprenone |
| 04/20/2011 | CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses |
| 04/20/2011 | CN101066313B Chinese medicine preparation for antagonizing bacteria and viruses of pig and improving pork quality, and its preparation process |
| 04/19/2011 | US7928219 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 04/19/2011 | US7928218 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 04/19/2011 | US7928143 Method for preventing and/or treating neurodegenerative diseases |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928097 Photoreactive compounds and compositions |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 04/19/2011 | US7927627 Nanoparticulate fibrate formulations |
| 04/19/2011 | US7927623 Pleasant taste; bioabsorbable; overcoated water insoluble drug in alcohol solvent and water soluble binder; mixing, compression |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | US7927598 Broad-spectrum δ-endotoxins and method and kit for detecting same and for detecting polynucleotides encoding same |
| 04/19/2011 | CA2621181C 5-isoquinolinesulfonamide compounds |
| 04/19/2011 | CA2571133C Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2474674C Solid preparation containing single crystal form |
| 04/19/2011 | CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2451680C Human dr4 antibodies and uses thereof |
| 04/19/2011 | CA2447703C Methods for proliferating terminal differentiated cells and recombinant vectors therefor |
| 04/19/2011 | CA2445048C Preparations containing afamin for treating oxidative stress-induced neurogenerative disease |
| 04/19/2011 | CA2439346C Method and device for manufacturing advanced water containing ultra-fine gold particles |
| 04/19/2011 | CA2394430C A calcium absorption enhancing agent and a method for producing it |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2384417C Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/19/2011 | CA2295625C Imidazole derivatives as mdr modulators |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | WO2011043456A1 Halogenated alkylsulfonamide derivative |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011043387A1 Pyrazoloxazole compound |
| 04/14/2011 | WO2011043381A1 Pyrazolothiazole compound |
| 04/14/2011 | WO2011043371A1 Oxazole compound |
| 04/14/2011 | WO2011043369A1 Water-soluble porphyrin and process for production thereof |
| 04/14/2011 | WO2011043359A1 Pharmaceutical product containing aromatic heterocyclic compound |